Cannell & Co’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $2.32M | Hold |
8,055
| – | – | 0.07% | 129 |
|
|
2023
Q3 | $2.16M | Hold |
8,055
| – | – | 0.07% | 123 |
|
|
2023
Q2 | $1.79M | Hold |
8,055
| – | – | 0.06% | 142 |
|
|
2023
Q1 | $1.95M | Sell |
8,055
-25
| -0.3% | -$6.14K | 0.07% | 136 |
|
|
2022
Q4 | $2.12M | Sell |
8,080
-1,375
| -15% | -$369K | 0.08% | 128 |
|
|
2022
Q3 | $2.13M | Buy |
9,455
+1,220
| +15% | +$296K | 0.08% | 122 |
|
|
2022
Q2 | $2M | Hold |
8,235
| – | – | 0.07% | 131 |
|
|
2022
Q1 | $1.99M | Hold |
8,235
| – | – | 0.06% | 143 |
|
|
2021
Q4 | $1.85M | Sell |
8,235
-400
| -5% | -$84.4K | 0.05% | 150 |
|
|
2021
Q3 | $1.84M | Sell |
8,635
-1,550
| -15% | -$357K | 0.06% | 150 |
|
|
2021
Q2 | $2.48M | Hold |
10,185
| – | – | 0.07% | 136 |
|
|
2021
Q1 | $2.53M | Hold |
10,185
| – | – | 0.08% | 132 |
|
|
2020
Q4 | $2.34M | Sell |
10,185
-150
| -1% | -$34.6K | 0.08% | 125 |
|
|
2020
Q3 | $2.63M | Sell |
10,335
-50
| -0.5% | -$12.4K | 0.1% | 110 |
|
|
2020
Q2 | $2.45M | Sell |
10,385
-150
| -1% | -$34.2K | 0.1% | 111 |
|
|
2020
Q1 | $2.14M | Sell |
10,535
-400
| -4% | -$87.4K | 0.1% | 115 |
|
|
2019
Q4 | $2.64M | Hold |
10,935
| – | – | 0.09% | 126 |
|
|
2019
Q3 | $2.12M | Hold |
10,935
| – | – | 0.08% | 128 |
|
|
2019
Q2 | $2.02M | Hold |
10,935
| – | – | 0.08% | 124 |
|
|
2019
Q1 | $2.08M | Buy |
10,935
+2,400
| +28% | +$458K | 0.08% | 124 |
|
|
2018
Q4 | $1.66M | Sell |
8,535
-100
| -1% | -$19.5K | 0.07% | 134 |
|
|
2018
Q3 | $1.79M | Sell |
8,635
-50
| -0.6% | -$9.85K | 0.06% | 141 |
|
|
2018
Q2 | $1.6M | Hold |
8,685
| – | – | 0.06% | 140 |
|
|
2018
Q1 | $1.48M | Hold |
8,685
| – | – | 0.06% | 145 |
|
|
2017
Q4 | $1.51M | Buy |
8,685
+150
| +2% | +$26.5K | 0.05% | 148 |
|
|
2017
Q3 | $1.59M | Hold |
8,535
| – | – | 0.06% | 147 |
|
|
2017
Q2 | $1.47M | Sell |
8,535
-100
| -1% | -$16.3K | 0.05% | 149 |
|
|
2017
Q1 | $1.42M | Buy |
8,635
+50
| +0.6% | +$8.31K | 0.05% | 159 |
|
|
2016
Q4 | $1.25M | Sell |
8,585
-400
| -4% | -$60.2K | 0.05% | 156 |
|
|
2016
Q3 | $1.5M | Buy |
8,985
+400
| +5% | +$67.6K | 0.05% | 150 |
|
|
2016
Q2 | $1.31M | Hold |
8,585
| – | – | 0.05% | 158 |
|
|
2016
Q1 | $1.29M | Sell |
8,585
-490
| -5% | -$72.8K | 0.05% | 159 |
|
|
2015
Q4 | $1.47M | Sell |
9,075
-175
| -2% | -$27.5K | 0.05% | 148 |
|
|
2015
Q3 | $1.28M | Sell |
9,250
-225
| -2% | -$35.5K | 0.04% | 160 |
|
|
2015
Q2 | $1.46M | Sell |
9,475
-125
| -1% | -$20K | 0.04% | 159 |
|
|
2015
Q1 | $1.53M | Hold |
9,600
| – | – | 0.04% | 154 |
|
|
2014
Q4 | $1.53M | Sell |
9,600
-1,200
| -11% | -$187K | 0.05% | 154 |
|
|
2014
Q3 | $1.52M | Hold |
10,800
| – | – | 0.05% | 154 |
|
|
2014
Q2 | $1.28M | Hold |
10,800
| – | – | 0.04% | 165 |
|
|
2014
Q1 | $1.33M | Buy |
10,800
+1,750
| +19% | +$212K | 0.04% | 165 |
|
|
2013
Q4 | $1.03M | Sell |
9,050
-50
| -0.5% | -$5.69K | 0.05% | 94 |
|
|
2013
Q3 | $1.02M | Hold |
9,100
| – | – | 0.06% | 94 |
|
|
2013
Q2 | $898K | Buy |
+9,100
| New | +$944K | 0.05% | 97 |
|
Other funds holding AMGN
Cannell & Co's AMGN Position: Q4 2023 in Review
Cannell & Co held its Amgen (AMGN) position steady in Q4 2023 at 8,055 shares worth $2.32M. The position accounts for 0.07% of the portfolio, ranked #129.
Cannell & Co first reported a position in AMGN in Q2 2013 and has held it in 43 quarters since. The position peaked at $2.64M in Q4 2019. 2,714 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.
- Cannell & Co held 8,055 shares of Amgen worth $2.32M as of Q4 2023.
- Cannell & Co left its Amgen share count unchanged in Q4 2023.
- Amgen made up 0.07% of Cannell & Co's portfolio in Q4 2023, its #129 holding.
- Cannell & Co first reported a position in Amgen in Q2 2013 and has held it in 43 quarters since.
- Cannell & Co's Amgen position peaked at $2.64M in Q4 2019.
- 2,714 funds tracked by Wall St. Rank held Amgen as of Q4 2023.
Based on Cannell & Co's 13F filing for Q4 2023, filed 5 Feb 2024.